Life Science seminar – HC Andersen Capital
Ascelia Pharma will present at the Life Science Seminar. To register: https://www.inderes.dk/videos/life-science-seminar
Life Science Podcast – Erik Penser Bank
Magnus Corfitzen will participate to the Life Science Podcast together with Erik Penser Bank.
The future of Swedish & Danish Life Science
Magnus Corfitzen will be presenting at The Future of Swedish & Danish Life Science http://www.swedishdanishlifescience.se/arrangement/index.xhtml
Erik Penser Banks Healthcare theme day
Erik Penser, Apelbergsgatan 27, 11137, StockholmJulie Waras Brogren, Deputy CEO & CCO will present Ascelia at the Erik Penser Bank Healthcare Theme Day. You can watch the event live: https://www.youtube.com/watch?v=BR6BNbpHcHU
Update on re-evaluation of Sparkle headline data
Magnus Corfitzen will be presenting at HC Andersen. To register to the event: https://www.inderes.dk/videos/ascelia-pharma-update-on-re-evaluation-of-sparkle-headline-data
Presentation of Q3 Interim Report 2023
Magnus Corfitzen will present Q3 2023 Interim Report at HC Andersen. To register to the event: https://www.inderes.dk/videos/ascelia-pharma-presentation-of-q3-2023
Jefferies London Healthcare Conference
Ascelia Pharma will attend the Jefferies Healthcare Conference.
Redeye Life Science Day
Sergelkonferensen, Mäster Samuelsgatan 42Julie Waras Brogren will present at Redeye Life Science Day. To register: https://www.redeye.se/events/915984/redeye-life-science-day-2023
Ascelia progress towards headline results of SPARKLE.
Redeye, Mäster Samuelsgatan Stockholm, SwedenAscelia will present the progress towards headline results of SPARKLE at Redeye.
Full-Year report 2023 with HC Andersen
Magnus Corfitzen will present the full year report 2023. To join register: https://www.inderes.dk/videos/ascelia-pharma-presentation-of-full-year-report-2023
Penser by Carnegie Company Day
Penser by Carnegie Apelbergsgatan 27, Stockholm, SwedenMagnus Corfitzen will be presenting at Penser by Carnegie Company Day. The event will also be livestreamed (in Room 3): https://youtube.com/playlist?list=PLFeVXfrcmwBBZOh_NjsLu2mH3-KYatyIY&si=Vw00086nDtH-rIiL
Annual General Meeting 2024
AGM 2024.
Investor Update – Tuesday 7 May at 14:00
Ascelia Pharma will give an investor update - please see link below to watch the event and send your questions prior to the event: Investor Update - Bringing Orviglance to patients
Interim Report Q1 2024
If you wish to participate via webcast, please use the link below. You can ask written questions through the webcast: https://ir.financialhearings.com/ascelia-pharma-q1-report-2024
HC Andersen – Presentation of Q1 2024
Magnus Corfitzen will present the Q1 interim report. To register to the event: Ascelia Pharma - What happened during Q1 2024
Carnegie Heathcare
Ascelia Pharma will present at the Carnegie Healthcare Conference.
HC Andersen – Life Science Seminar
Ascelia Pharma will present at the HC Andersen Life Science Seminar, to attend: https://www.inderes.dk/videos/life-science-seminar-2024
Commercial and partnership strategy
Julie Waras Brogren, Deputy CEO will present the commercial and partnership strategy for Orviglance, to register and submit your questions: Ascelia Pharma commercial and partnership strategy